Trials / Unknown
UnknownNCT04138186
G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea
A Randomized, Placebo Controlled, Double-blind, Parallel-arm Feasibility (Pilot) Study to Evaluate Safety and Clinical Efficacy of G-PUR® Treatment in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Glock Health, Science and Research GmbH · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, double-blind, placebo-controlled pilot study in patients with IBS-D according to Rome IV criteria evaluating the clinical efficacy and safety of oral administration of 2g G-PUR® tid compared to placebo in a cohort of 30 patients over an active treatment period of 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 2.0g G-PUR®, oral administration | tid for 12 weeks |
| DEVICE | Placebo, oral administration | tid for 12 weeks |
Timeline
- Start date
- 2019-10-02
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2019-10-24
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04138186. Inclusion in this directory is not an endorsement.